Biologic anti-IL17 drugs in erythrodermic psoriasisCapsule Summary

• Autori principali: Alessandro Falco, MD (Autore), Cristina Mugheddu, MD (Autore), Jasmine Anedda, MD (Autore), Laura Pizzatti, MD (Autore), Alice Tatti, MD (Autore), Brunella Conti, MD (Autore), Laura Atzori, MD (Autore)
• Natura: Libro
• Pubblicazione: Elsevier, 2024-09-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Background: Erythrodermic psoriasis (EP) is a potentially life-threatening disease, and there is currently no consensus regarding its optimal treatment. Biological drugs approved for Psoriasis Vulgaris treatment have been used as alternatives to traditional medications. Objective: To evaluate the cl...